Upload File

The top documents tagged [metastatic setting]

A Guide to the Diagnosis, Treatment and Follow-Up of Bladder and Kidney Cancer. Dr Manish Patel MB.BS., MMed., FRACS Urological Oncologist Westmead Hospital
A Guide to the Diagnosis, Treatment and Follow-Up of Bladder and Kidney Cancer. Dr Manish Patel MB.BS., MMed., FRACS Urological Oncologist Westmead Hospital
217 views
PREGNANCY ASSOCIATED BREAST CANCER
PREGNANCY ASSOCIATED BREAST CANCER
188 views
Cervical Cancer Ppt Management
Cervical Cancer Ppt Management
772 views
©American Society of Clinical Oncology 2008 American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation
©American Society of Clinical Oncology 2008 American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation
223 views
Colorectal Cancer Poster Discussion Discussion of Posters #17 - 25 Wells Messersmith, MD, FACP Director, GI Medical Oncology Program Leader, Developmental
Colorectal Cancer Poster Discussion Discussion of Posters #17 - 25 Wells Messersmith, MD, FACP Director, GI Medical Oncology Program Leader, Developmental
216 views
OLD AND NEW ANTHACYCLINES: A STILL VALID OPTION IN BREAST CANCER TREATMENT True: Clara Natoli
OLD AND NEW ANTHACYCLINES: A STILL VALID OPTION IN BREAST CANCER TREATMENT True: Clara Natoli
214 views
Up-to-Date Review A Review of 2007 Breast Cancer Highlights Harold J. Burstein, MD, PhD Assistant Professor of Medicine Dana Farber Cancer Institute Breast
Up-to-Date Review A Review of 2007 Breast Cancer Highlights Harold J. Burstein, MD, PhD Assistant Professor of Medicine Dana Farber Cancer Institute Breast
219 views
Locally advanced and metastatic disease Eribulin mesylate (E7389): review of efficacy and tolerability Jennifer Foglietta Ospedale Santa Maria della Misericordia
Locally advanced and metastatic disease Eribulin mesylate (E7389): review of efficacy and tolerability Jennifer Foglietta Ospedale Santa Maria della Misericordia
215 views
Nuovi inibitori irreversibili di EGFR Cesare Gridelli Division of Medical Oncology “S.G. Moscati” Hospital – Avellino (Italy) cgridelli@libero.it cgridelli@libero.it
Nuovi inibitori irreversibili di EGFR Cesare Gridelli Division of Medical Oncology “S.G. Moscati” Hospital – Avellino (Italy) [email protected] [email protected]
212 views
An odyssey into the land of rare tumours: adenocarcinoma of small bowel and endocrine tumours
An odyssey into the land of rare tumours: adenocarcinoma of small bowel and endocrine tumours
17 views
Novel Her-2- neu Targeted Agents Jame Abraham, M.D, FACP Bonnie Wells Wilson Distinguished Professor Chief, Section of Hematology-Oncology West Virginia
Novel Her-2- neu Targeted Agents Jame Abraham, M.D, FACP Bonnie Wells Wilson Distinguished Professor Chief, Section of Hematology-Oncology West Virginia
221 views
Whom to treat and how long to treat after resection of GIST Professor John R Zalcberg Chief Medical Officer & Director, Division of Cancer Medicine Peter
Whom to treat and how long to treat after resection of GIST Professor John R Zalcberg Chief Medical Officer & Director, Division of Cancer Medicine Peter
226 views